Kala Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $70 |
Gross Profit | -61 | -66 | 0 |
EBITDA | -8,060 | -10,286 | -7,089 |
EBIT | -8,121 | -10,352 | -7,159 |
Net Income | -9,579 | -11,807 | -8,627 |
Net Change In Cash | 0 | 0 | 70 |
Free Cash Flow | -9,251 | -10,857 | -7,703 |
Cash | 54,197 | 48,478 | 50,895 |
Basic Shares | 3,030 | 2,813 | 2,712 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $3,892 | $11,240 | $6,362 |
Gross Profit | -303 | 1,332 | 7,143 | 3,189 |
EBITDA | -36,082 | -36,696 | -131,957 | -92,902 |
EBIT | -36,385 | -37,556 | -134,225 | -95,738 |
Net Income | -42,199 | -223 | -152,296 | -112,004 |
Net Change In Cash | 0 | 3,892 | 11,240 | 6,362 |
Cost of Revenue | -8,275 | |||
Free Cash Flow | -28,537 | -79,221 | -109,121 | -92,636 |
Cash | 50,895 | 70,495 | 92,136 | 77,264 |
Basic Shares | 2,432 | 1,520 | 1,304 | 1,047 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.93 |
2024-06-30 | -$3.16 |
2024-03-31 | -$4.19 |
2023-12-31 | -$3.18 |
